The study suggested that the markers YKL-40 (CHI3L1), a glycoprotein derived from astrocytes, and GFAP (a marker related to astrogliosis) detected in plasma, could serve as effective indicators, particularly in pre-dementia patients [78]. Here, GFAP is linked to dementia.